 | • レポートコード：MRC2-11QY12551 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺癌のグローバル市場について調査・分析したレポートです。種類別（手術、化学療法、放射線療法、光線力学療法、レーザー療法）市場規模、用途別（病院・クリニック、がん研究センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺癌の競争状況、市場シェア ・世界の肺癌市場：種類別市場規模 2015年-2020年（手術、化学療法、放射線療法、光線力学療法、レーザー療法） ・世界の肺癌市場：種類別市場規模予測 2021年-2026年（手術、化学療法、放射線療法、光線力学療法、レーザー療法） ・世界の肺癌市場：用途別市場規模 2015年-2020年（病院・クリニック、がん研究センター、研究所） ・世界の肺癌市場：用途別市場規模予測 2021年-2026年（病院・クリニック、がん研究センター、研究所） ・北米の肺癌市場分析：米国、カナダ ・ヨーロッパの肺癌市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺癌市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺癌市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺癌市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Novartis、Pfizer、Merck、Bristol-Myers Squibb、Eli Lilly And Company、Sanof ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.
Market Analysis and Insights: Global Lung Cancer Market
The global Lung Cancer market size is projected to reach US$ 20050 million by 2026, from US$ 18520 million in 2020, at a CAGR of 7.7%% during 2021-2026.
Global Lung Cancer Scope and Market Size
Lung Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Novartis
Pfizer
Merck
Bristol-Myers Squibb
Eli Lilly And Company
Sanof
…
Market segment by Type, the product can be split into
Surgery
Chemotherapy
Radiotherapy
Photodynamic Therapy
Laser Therapy
Market segment by Application, split into
Hospital & Clinics
Cancer Research Centers
Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Revenue
1.4 Market by Type
1.4.1 Global Lung Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Chemotherapy
1.4.4 Radiotherapy
1.4.5 Photodynamic Therapy
1.4.6 Laser Therapy
1.5 Market by Application
1.5.1 Global Lung Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospital & Clinics
1.5.3 Cancer Research Centers
1.5.4 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Market Perspective (2015-2026)
2.2 Global Lung Cancer Growth Trends by Regions
2.2.1 Lung Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lung Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Lung Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lung Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Lung Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Players by Market Size
3.1.1 Global Top Lung Cancer Players by Revenue (2015-2020)
3.1.2 Global Lung Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Lung Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Market Concentration Ratio
3.2.1 Global Lung Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Revenue in 2019
3.3 Lung Cancer Key Players Head office and Area Served
3.4 Key Players Lung Cancer Product Solution and Service
3.5 Date of Enter into Lung Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lung Cancer Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lung Cancer Market Size by Application (2015-2020)
5.2 Global Lung Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lung Cancer Market Size (2015-2020)
6.2 Lung Cancer Key Players in North America (2019-2020)
6.3 North America Lung Cancer Market Size by Type (2015-2020)
6.4 North America Lung Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lung Cancer Market Size (2015-2020)
7.2 Lung Cancer Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Market Size by Application (2015-2020)
8 China
8.1 China Lung Cancer Market Size (2015-2020)
8.2 Lung Cancer Key Players in China (2019-2020)
8.3 China Lung Cancer Market Size by Type (2015-2020)
8.4 China Lung Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lung Cancer Market Size (2015-2020)
9.2 Lung Cancer Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lung Cancer Market Size (2015-2020)
10.2 Lung Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Market Size by Application (2015-2020)
11 India
11.1 India Lung Cancer Market Size (2015-2020)
11.2 Lung Cancer Key Players in India (2019-2020)
11.3 India Lung Cancer Market Size by Type (2015-2020)
11.4 India Lung Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lung Cancer Market Size (2015-2020)
12.2 Lung Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Lung Cancer Introduction
13.1.4 Roche Revenue in Lung Cancer Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Lung Cancer Introduction
13.2.4 Novartis Revenue in Lung Cancer Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Lung Cancer Introduction
13.3.4 Pfizer Revenue in Lung Cancer Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Lung Cancer Introduction
13.4.4 Merck Revenue in Lung Cancer Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview
13.5.3 Bristol-Myers Squibb Lung Cancer Introduction
13.5.4 Bristol-Myers Squibb Revenue in Lung Cancer Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Eli Lilly And Company
13.6.1 Eli Lilly And Company Company Details
13.6.2 Eli Lilly And Company Business Overview
13.6.3 Eli Lilly And Company Lung Cancer Introduction
13.6.4 Eli Lilly And Company Revenue in Lung Cancer Business (2015-2020)
13.6.5 Eli Lilly And Company Recent Development
13.7 Sanof
13.7.1 Sanof Company Details
13.7.2 Sanof Business Overview
13.7.3 Sanof Lung Cancer Introduction
13.7.4 Sanof Revenue in Lung Cancer Business (2015-2020)
13.7.5 Sanof Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lung Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Lung Cancer Revenue
Table 3. Ranking of Global Top Lung Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lung Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiotherapy
Table 8. Key Players of Photodynamic Therapy
Table 9. Key Players of Laser Therapy
Table 10. Global Lung Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Lung Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Lung Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Lung Cancer Market Share by Regions (2015-2020)
Table 14. Global Lung Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Lung Cancer Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Lung Cancer Market Growth Strategy
Table 20. Main Points Interviewed from Key Lung Cancer Players
Table 21. Global Lung Cancer Revenue by Players (2015-2020) (Million US$)
Table 22. Global Lung Cancer Market Share by Players (2015-2020)
Table 23. Global Top Lung Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer as of 2019)
Table 24. Global Lung Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Lung Cancer Product Solution and Service
Table 27. Date of Enter into Lung Cancer Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Lung Cancer Market Size by Type (2015-2020) (Million US$)
Table 30. Global Lung Cancer Market Size Share by Type (2015-2020)
Table 31. Global Lung Cancer Revenue Market Share by Type (2021-2026)
Table 32. Global Lung Cancer Market Size Share by Application (2015-2020)
Table 33. Global Lung Cancer Market Size by Application (2015-2020) (Million US$)
Table 34. Global Lung Cancer Market Size Share by Application (2021-2026)
Table 35. North America Key Players Lung Cancer Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Lung Cancer Market Share (2019-2020)
Table 37. North America Lung Cancer Market Size by Type (2015-2020) (Million US$)
Table 38. North America Lung Cancer Market Share by Type (2015-2020)
Table 39. North America Lung Cancer Market Size by Application (2015-2020) (Million US$)
Table 40. North America Lung Cancer Market Share by Application (2015-2020)
Table 41. Europe Key Players Lung Cancer Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Lung Cancer Market Share (2019-2020)
Table 43. Europe Lung Cancer Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Lung Cancer Market Share by Type (2015-2020)
Table 45. Europe Lung Cancer Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Lung Cancer Market Share by Application (2015-2020)
Table 47. China Key Players Lung Cancer Revenue (2019-2020) (Million US$)
Table 48. China Key Players Lung Cancer Market Share (2019-2020)
Table 49. China Lung Cancer Market Size by Type (2015-2020) (Million US$)
Table 50. China Lung Cancer Market Share by Type (2015-2020)
Table 51. China Lung Cancer Market Size by Application (2015-2020) (Million US$)
Table 52. China Lung Cancer Market Share by Application (2015-2020)
Table 53. Japan Key Players Lung Cancer Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Lung Cancer Market Share (2019-2020)
Table 55. Japan Lung Cancer Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Lung Cancer Market Share by Type (2015-2020)
Table 57. Japan Lung Cancer Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Lung Cancer Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Lung Cancer Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Lung Cancer Market Share (2019-2020)
Table 61. Southeast Asia Lung Cancer Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Lung Cancer Market Share by Type (2015-2020)
Table 63. Southeast Asia Lung Cancer Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Lung Cancer Market Share by Application (2015-2020)
Table 65. India Key Players Lung Cancer Revenue (2019-2020) (Million US$)
Table 66. India Key Players Lung Cancer Market Share (2019-2020)
Table 67. India Lung Cancer Market Size by Type (2015-2020) (Million US$)
Table 68. India Lung Cancer Market Share by Type (2015-2020)
Table 69. India Lung Cancer Market Size by Application (2015-2020) (Million US$)
Table 70. India Lung Cancer Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Lung Cancer Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Lung Cancer Market Share (2019-2020)
Table 73. Central & South America Lung Cancer Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Lung Cancer Market Share by Type (2015-2020)
Table 75. Central & South America Lung Cancer Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Lung Cancer Market Share by Application (2015-2020)
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Product
Table 80. Roche Revenue in Lung Cancer Business (2015-2020) (Million US$)
Table 81. Roche Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Lung Cancer Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Lung Cancer Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Product
Table 95. Merck Revenue in Lung Cancer Business (2015-2020) (Million US$)
Table 96. Merck Recent Development
Table 97. Bristol-Myers Squibb Company Details
Table 98. Bristol-Myers Squibb Business Overview
Table 99. Bristol-Myers Squibb Product
Table 100. Bristol-Myers Squibb Revenue in Lung Cancer Business (2015-2020) (Million US$)
Table 101. Bristol-Myers Squibb Recent Development
Table 102. Eli Lilly And Company Company Details
Table 103. Eli Lilly And Company Business Overview
Table 104. Eli Lilly And Company Product
Table 105. Eli Lilly And Company Revenue in Lung Cancer Business (2015-2020) (Million US$)
Table 106. Eli Lilly And Company Recent Development
Table 107. Sanof Company Details
Table 108. Sanof Business Overview
Table 109. Sanof Product
Table 110. Sanof Revenue in Lung Cancer Business (2015-2020) (Million US$)
Table 111. Sanof Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiotherapy Features
Figure 5. Photodynamic Therapy Features
Figure 6. Laser Therapy Features
Figure 7. Global Lung Cancer Market Share by Application: 2020 VS 2026
Figure 8. Hospital & Clinics Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Laboratories Case Studies
Figure 11. Lung Cancer Report Years Considered
Figure 12. Global Lung Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Lung Cancer Market Share by Regions: 2020 VS 2026
Figure 14. Global Lung Cancer Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Lung Cancer Market Share by Players in 2019
Figure 17. Global Top Lung Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Revenue in 2019
Figure 19. North America Lung Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Lung Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Lung Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Lung Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Lung Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Lung Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Lung Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…- 小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
- 肺がんリキッドバイオプシーの世界市場（～2026年） Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. Market Analysis and Insigh…
- 非小細胞肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Non-small Cell Lung Cancer Therapeu…
- 肺がん診断・治療の世界市場（～2026年） Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the …